Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report
Abstract Immune checkpoint inhibitors (ICIs) have been shown to improve survival in patients with advanced or metastatic esophageal cancer. However, ICI‐based rechallenges after recovery from fatal adverse events (AEs) are equivocal, especially in patients who have already undergone treatment‐relate...
Main Authors: | Yanhong Yao, Zhentao Liu, Qian Li, Baoshan Cao, Mopei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14279 |
Similar Items
-
Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions
by: Mengjie Jiang, et al.
Published: (2023-05-01) -
Radiotherapy combined with immune checkpoint inhibitors in locally advanced/metastatic esophageal squamous cell carcinoma: clinical trials, efficacy and future directions
by: Mengjie Jiang, et al.
Published: (2023-05-01) -
Refractory tracheoesophageal fistula treated using multi-stage surgery: A case report
by: Yoichi Nakagawa, et al.
Published: (2022-12-01) -
Routine Fogarty Catheter Occlusion of Fistula in Esophageal Atresia with Tracheoesophageal Fistula Surgery: A Retrospective Study
by: Darunee Sripadungkul, et al.
Published: (2023-05-01) -
Efficacy and safety of PD-1 inhibitors as second-line treatment for advanced squamous esophageal cancer: a systematic review and network meta-analysis with a focus on PD-L1 expression levels
by: Fei Yang, et al.
Published: (2025-01-01)